Gamma Vaccines receives R&D tax credit.

Gamma vaccines receives an R&D Tax Credit for R&D conducted in FY2023 for the amount of $28,538.84.

Share this post

05/10/2024
Gamma Vaccines acquires IP to develop NDV vaccine
Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise…

Read article
12/09/2024
Gamma vaccines signs international collaboration agreement.
Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to…

Read article
05/09/2024
Gamma Vaccines files patent on combination vaccines
Gamma Vaccines has filed a patent application on combination vaccines that incorporate our photon-inactivated vaccine with other immunogens,…

Read article